ISOCRATIC RP-HPLC, UV METHOD DEVELOPMENT AND VALIDATION OF ITRACONAZOLE IN CAPSULE DOSAGE FORM

被引:7
作者
Kumudhavalli, M. V. [1 ]
机构
[1] Vinayaka Miss Coll Pharm, Dept Pharmaceut Anal, Salem 636008, Tamil Nadu, India
关键词
Itraconazole; HPLC; Linearity; Validation;
D O I
10.13040/IJPSR.0975-8232.2(12).3269-71
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simple, specific, accurate and precise reverse phase high performance liquid chromatographic method was developed and validated for the estimation of Itraconazole in capsule dosage form. An inertsil C-18, 5 mu m column having 250 x 4.6mm internal diameter in isocratic mode with mobile phase containing Tetrabutyl ammonium hydrogen sulphate buffer solution and Acetonitrile in the ratio of 40: 60v/v was used. The flow rate was 1.5ml/min and effluents were monitored at 225nm. The retention time for Itraconazole was 5.617min. The method was validated for linearity, accuracy, precision, specificity, limit of detection, limit of quantification and robustness. Limit of detection and limit of quantification were found to be 0.85 mu g/ml and 2.60 mu g/ml respectively and recovery of Itraconazole from capsule formulation was found to be 98.3 to 100.3%. The system suitability parameters such as theoretical plates and tailing factor were found to be 2927.43 and 1.08 The proposed method was successfully applied for the quantitative determination of Itraconazole in capsule formulation.
引用
收藏
页码:3269 / 3271
页数:3
相关论文
共 10 条
[1]  
[Anonymous], 2002, JANSS PHARM PROD SPO
[2]   Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: Application to a bioequivalence study [J].
Bharathi, D. Vijaya ;
Hotha, Kishore Kumar ;
Sagar, P. V. Vidya ;
Kumar, Sanagapati Sirish ;
Reddy, Pandu Ranga ;
Naidu, A. ;
Mullangi, Ramesh .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 868 (1-2) :70-76
[3]  
Chandiran I. S., 2011, Der Pharmacia Lettre, V3, P316
[4]   Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis [J].
Conway, SP ;
Etherington, C ;
Peckham, DG ;
Brownlee, KG ;
Whitehead, A ;
Cunliffe, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :841-847
[5]   Microassay for determination of itraconazole and hydroxyitraconazole in plasma and tissue biopsies [J].
Cox, SK ;
Orosz, S ;
Burnette, J ;
Frazier, D .
JOURNAL OF CHROMATOGRAPHY B, 1997, 702 (1-2) :175-180
[6]   Pharmacology of itraconazole [J].
De Beule, K ;
Van Gestel, J .
DRUGS, 2001, 61 (Suppl 1) :27-37
[7]   CYCLOSPORINE AND ITRACONAZOLE INTERACTION IN HEART AND LUNG-TRANSPLANT RECIPIENTS [J].
KRAMER, MR ;
MARSHALL, SE ;
DENNING, DW ;
KEOGH, AM ;
TUCKER, RM ;
GALGIANI, JN ;
LEWISTON, NJ ;
STEVENS, DA ;
THEODORE, J .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (04) :327-329
[8]   DETERMINATION OF ITRACONAZOLE AND ITS ACTIVE METABOLITE IN PLASMA BY COLUMN LIQUID-CHROMATOGRAPHY [J].
POIRIER, JM ;
LEBOT, M ;
DESCAMPS, P ;
LEVY, M ;
CHEYMOL, G .
THERAPEUTIC DRUG MONITORING, 1994, 16 (06) :596-601
[9]  
Redmann Stefanie, BIOMEDICAL CHROMATOG, V20, P343
[10]   Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high-performance liquid chromatography [J].
Srivatsan, V ;
Dasgupta, AK ;
Kale, P ;
Datla, RR ;
Soni, D ;
Patel, M ;
Patel, R ;
Mavadhiya, C .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1031 (1-2) :307-313